Chen Y, Hu R, Jin C, Huang L, Lin Y, Zou B
BMC Cancer. 2025; 25(1):469.
PMID: 40087677
DOI: 10.1186/s12885-025-13847-0.
Kim J, Park K, Han K, Jung J, Oh S, Rhiu S
PLoS One. 2025; 20(3):e0319872.
PMID: 40073024
PMC: 11902197.
DOI: 10.1371/journal.pone.0319872.
Valerio L, Matrone A
Explor Target Antitumor Ther. 2025; 6:1002291.
PMID: 40061140
PMC: 11886382.
DOI: 10.37349/etat.2025.1002291.
Li G, Li R, Zhong J, Chen W, Shuai J, Chen M
Nat Commun. 2025; 16(1):2317.
PMID: 40057484
PMC: 11890561.
DOI: 10.1038/s41467-025-57627-7.
Hlozek J, Rotnagl J, Holy R, Hlozkova T, Pekova Bulanova B, Kuklikova V
J Appl Biomed. 2025; 22(4):214-220.
PMID: 40033809
DOI: 10.32725/jab.2024.025.
Simultaneous Medullary and Papillary Thyroid Carcinomas: Personal Experience Report and Literature Review.
De Falco N, Agresti M, De Falco M, Sperlongano P, Moccia G, Luongo P
J Clin Med. 2025; 14(4).
PMID: 40004911
PMC: 11856133.
DOI: 10.3390/jcm14041382.
Radiofrequency Ablation for Locoregional Structural Incomplete Response in Differentiated Thyroid Cancer: Initial Experience in Greece.
Simeakis G, Kapama A, Paparodis R, Gkousis P, Koursaros P, Kokkinis C
Biomedicines. 2025; 13(2).
PMID: 40002668
PMC: 11852475.
DOI: 10.3390/biomedicines13020255.
Correlation analysis of Hashimoto's thyroiditis with papillary thyroid carcinoma occurrence and its central lymph node metastasis: a single center experience.
Sun K, Wang X, Chen D, Ma C
Front Endocrinol (Lausanne). 2025; 15:1420998.
PMID: 39981137
PMC: 11840962.
DOI: 10.3389/fendo.2024.1420998.
Risk factors and prediction model for cancer-related cognitive impairment in thyroid cancer patients.
Ni T, Sun J, He Q, Dai Y, Wang X, Yu E
Am J Cancer Res. 2025; 15(1):153-167.
PMID: 39949943
PMC: 11815387.
DOI: 10.62347/AOTU1301.
The impact of C216T and hot spot mutations of the TERT promoter on the clinicopathologic characteristics and S100A10 expression in papillary thyroid carcinoma: a comparative study.
Li P, Huang C, Liu X, Gui H, Li J
Diagn Pathol. 2025; 20(1):15.
PMID: 39934880
PMC: 11816782.
DOI: 10.1186/s13000-025-01613-6.
Unusual Skull Metastasis From Thyroid Cancer: A Case Report.
Guzman Lopez J, Diaz Acosta J, Rivera Contreras O, Zamora Rangel C, Manrique Hernandez E
Cureus. 2025; 17(1):e77234.
PMID: 39925556
PMC: 11807390.
DOI: 10.7759/cureus.77234.
Radioactive Iodine Therapy in Differentiated Thyroid Cancer: Summary of the Korean Thyroid Association Guidelines 2024 from Nuclear Medicine Perspective, Part-II.
Oh S, Park S, Chong A, Kim K, Bang J, Seo Y
Nucl Med Mol Imaging. 2025; 59(1):8-26.
PMID: 39881975
PMC: 11772646.
DOI: 10.1007/s13139-024-00886-x.
Nuclear Medicine Imaging in Differentiated Thyroid Cancer: Summary of the Korean Thyroid Association Guidelines 2024 from Nuclear Medicine Perspective, Part-I.
Oh S, Park S, Chong A, Kim K, Bang J, Seo Y
Nucl Med Mol Imaging. 2025; 59(1):1-7.
PMID: 39881973
PMC: 11772645.
DOI: 10.1007/s13139-024-00885-y.
Pretreatment level of circulating tumor cells is associated with lymph node metastasis in papillary thyroid carcinoma patients with ≤ 55 years old.
Yu M, Deng J, Gu Y, Lai Y, Wang Y
World J Surg Oncol. 2025; 23(1):29.
PMID: 39881336
PMC: 11776172.
DOI: 10.1186/s12957-025-03670-z.
A 46-Year-Old Man with an Incidental Finding of a Papillary Thyroid Carcinoma in a Thyroglossal Duct Cyst.
Witkowska A, Rot P, Wojdas A
Am J Case Rep. 2025; 25():e945625.
PMID: 39817317
PMC: 11702471.
DOI: 10.12659/AJCR.945625.
Narrative overview of possible preventive measures for differentiated thyroid carcinomas.
Castro M, Cunha L, Ward L
Heliyon. 2025; 11(1):e41284.
PMID: 39811343
PMC: 11731471.
DOI: 10.1016/j.heliyon.2024.e41284.
Protocol for the development of a global core outcome set for the surgical treatment of differentiated thyroid cancer: a literature review and international Delphi survey.
van de Berg D, Mooij C, van Trotsenburg A, Jamaludin F, van Santen H, Clement S
BMJ Open. 2025; 15(1):e084391.
PMID: 39800407
PMC: 11751832.
DOI: 10.1136/bmjopen-2024-084391.
Vocal Outcome Following Thyroidectomy for Differentiated Thyroid Carcinoma.
Rosa M, Dellera V, Campagnoli M, Campini S, Barozza O, Borello G
J Clin Med. 2025; 13(24.
PMID: 39768499
PMC: 11728086.
DOI: 10.3390/jcm13247576.
Treatment Outcomes and Toxicities of Multiple Tyrosin Kinase Inhibitors for Metastatic Medullary Thyroid Cancer: A Case Series.
Mormando M, Lauretta R, Puliani G, Bianchini M, Spoltore M, Appetecchia M
Biomedicines. 2025; 12(12.
PMID: 39767829
PMC: 11673415.
DOI: 10.3390/biomedicines12122923.
Comprehensive analysis of clinicopathologic and prognostic features in locally advanced thyroid papillary cancer.
Jiwang L, Dongman Y, Fengqin F, Yuejiao Z
Braz J Otorhinolaryngol. 2025; 91(2):101553.
PMID: 39753045
PMC: 11753965.
DOI: 10.1016/j.bjorl.2024.101553.
